Discontinued — last reported Q4 '20
Products & Services · Potential milestone payments
Development Product Candidates — Potential milestone payments
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ2 2020
Last reportedQ4 2020Feb 5, 2021
How to read this metric
An increase suggests a growing pipeline of high-potential assets or expanded partnership agreements, while a decrease may indicate the successful achievement of milestones or the termination of development programs.
Detailed definition
This metric represents the aggregate future financial obligations or potential inflows associated with achieving specifi...
Peer comparison
Comparable to 'contingent consideration' or 'milestone revenue potential' reported by other biopharmaceutical companies with active licensing or collaboration agreements.
Metric ID:
nbix_segment_development_product_candidates_potential_milestone_paymentsSimilar Metrics at Other Companies
Frequently Asked Questions
- What does development product candidates — potential milestone payments mean?
- The total value of future payments tied to reaching specific clinical or regulatory goals for drug development projects.